ANGPTL1 and neoplasm: The protein of ANGPTL1 could impede vascular leakiness to inhibit CRC‐LM; however, the level of ANGPTL1 is decreased in the EVs from CRC tumour tissues compared to that in normal tissues (Jiang et al., 2021).